Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities

Summary by AI BETAClose X

Novonesis has announced its intent to acquire the remaining share of MicroBioGen, an Australian biotechnology company specializing in yeast strains for industrial applications, particularly in bioethanol. This move builds upon Novonesis' existing 23% stake and a decade-long collaboration, aiming to strengthen its yeast capabilities and R&D. The transaction terms are undisclosed, and completion is subject to regulatory approvals. Novonesis will continue to support MicroBioGen's existing partners, ensuring continuity in collaborations.

Disclaimer*

UK 100

Latest directors dealings